Stephen P Ewald
CIK 1677297 · View on SEC EDGAR ↗
First SEC filing: Aug. 10, 2016 · Latest: Aug. 10, 2016
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | MEDP | S | 16,349 | $450.00 | $7,357,050 | 20,343 Direct | -44.56% | Disposed | 37.3% (price as of 2026-08-20) |
| July 27, 2023 | MEDP | S | 21,850 | $254.39 | $5,558,422 | 14,854 Direct | -59.53% | Disposed | 142.8% (price as of 2026-08-20) |
| April 15, 2021 | MEDP | S | 3,800 | $185.18 | $703,684 | 13,854 Direct | -21.52% | Disposed | 233.6% (price as of 2026-08-20) |
| April 14, 2021 | MEDP | S | 1,200 | $180.67 | $216,804 | 13,854 Direct | -7.97% | Disposed | 241.9% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (16,349) | $138.87 | Aug. 15, 2027 | 16,349 | Disposed |
| July 27, 2023 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (21,850) | $107.93 | Feb. 28, 2026 | 21,850 | Disposed |
| April 15, 2021 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (3,800) | $28.32 | March 15, 2024 | 3,800 | Disposed |
| April 14, 2021 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (1,200) | $28.32 | March 15, 2024 | 1,200 | Disposed |
| Feb. 28, 2018 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (7,500) | $32.05 | Feb. 28, 2025 | 7,500 | Acquired |
| March 15, 2017 | MEDP | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | COMMON STOCK (5,000) | $28.32 | March 15, 2024 | 5,000 | Acquired |
| Aug. 10, 2016 | MEDP | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | Common Stock (7,400) | $23.00 | Aug. 10, 2023 | 7,400 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 10, 2016 | MEDP | Employee Stock Option (right to buy)→ Common Stock (18,518) | 18,518 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MEDP
General Counsel| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $591,507 | $414,150 | — | — | — | — | $14,000 | $2,019,709 |
| 2024 | $564,200 | $296,250 | — | — | — | — | $11,500 | $3,699,450 |
| 2023 | $531,325 | $372,068 | — | — | — | — | $11,250 | $914,643 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.